Healthtech Startups

BBy develops a condensed breast milk product and process that preserves bioactive immunological properties for hospital distribution. The company serves hospitals, lactating mothers with supply challenges, and families needing access to safe, affordable breast milk nutrition.

4 investors

Beep is a fully digital home healthcare service that provides laboratory tests (5,000+ types), vaccines, and infusions at the patient's home, booked via its app or website. It serves individuals paying privately or through more than 40 accepted health insurance plans, operating in Rio de Janeiro, São Paulo, and Brasília, Brazil.

4 investors

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation. It serves sponsors, CROs, site networks, and research sites in the clinical research and life sciences industry.

4 investors

Belong Health provides a full-stack health plan operating platform and partnership model that helps organizations design and run health plans, sharing the risk of launching and building them. It focuses on patient engagement using behavioral science to improve care and reduce cost for underserved and complex populations, particularly Medicare and Medicaid-type members.

4 investors

BestDoc provides a suite of patient relationship management and omni-channel engagement products for hospitals to streamline operations from scheduling through discharge. The company serves hospitals across India and the Middle East, having reached over 4 million patients across more than 250 facilities.

4 investors

An educational content platform that publishes curated Bible verses and spiritual guidance, with a complementary mobile app that provides biblical teachings and daily devotional content.

4 investors

Bigfoot Biomedical develops a diabetes management system that combines continuous glucose monitor data with a doctor's instructions to give insulin dose recommendations. It serves people with diabetes who use multiple daily injections of insulin.

4 investors

Biocartis develops molecular diagnostic testing systems for cancer, with a focus on enabling personalized medicine through rapid, in-house biomarker analysis. The company's Idylla Platform automates molecular testing to help clinicians and patients access treatment information quickly.

4 investors

Biohaven is a pharmaceutical company that discovers, develops, and commercializes medications for neurological and neuropsychiatric diseases, including epilepsy, pain, mood disorders, OCD, spinocerebellar ataxia, and spinal muscular atrophy. The company operates as a modern publicly traded entity and was acquired by Pfizer in May 2022 for approximately $13 billion.

4 investors

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options. Its commercialized products include migraine therapies, and it advances a portfolio of early- to late-stage drug development programs.

4 investors

BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.

4 investors

Biologica produces stage-specific effervescent multivitamin drinks formulated for women's hormonal health at different life stages. The products combine vitamins, minerals, probiotics, and electrolytes to address both acute hormonal symptoms and overall wellness across brain, heart, bones, and muscles.

4 investors

Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.

4 investors

Biomodal develops genomic and epigenomic sequencing technologies for life scientists and clinical researchers, enabling simultaneous analysis of genetic data and modified cytosine bases from a single DNA sample. The company's tools integrate pre- and post-sequencing workflows to capture both canonical and modified bases in the genome.

4 investors

BioMotum develops wearable mobility devices aimed at improving patient outcomes, serving medical professionals and patients in the medical device and digital health space. The company focuses on making wearable mobility technology more affordable and accessible.

4 investors

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease. Its pipeline includes TL1A, TL1A*IL-23p19 bispecific, and IL-25 antibodies with half-life extension technology.

4 investors

Biosense Technologies designs portable and affordable diagnostic devices for basic healthcare screening, leveraging digital technology to address gaps in access to diagnostic services across India's healthcare system.

4 investors

Blueberry provides 24/7 pediatric telemedicine services with an at-home medical kit for families, enabling remote diagnosis and care from board-certified pediatricians.

4 investors

Bluebird Kids Health provides pediatric care services with a family-centered approach. The company aims to transform healthcare delivery for children and their families.

4 investors

Blueprint Genetics is a genetic testing company that combines laboratory science, genetics, and bioinformatics to analyze and interpret genetic data. It operates as a global company with in-house software, cloud, and bioinformatics teams supporting its testing services.

4 investors

BrainSightAI develops AI-based neuroimaging products that analyze MRI data to provide evidence-based treatment guidance for neurosurgeons, psychiatrists, and neurologists, along with a digital aid for patients. The company works in brain mapping and connectivity at the intersection of neuroscience and machine learning, serving hospitals and clinical teams.

4 investors

BrainSpec develops software for analyzing and visualizing MR spectroscopy (MRS) neuroimaging data, aiming to make a non-invasive "virtual biopsy" available to clinicians and researchers. Its technology targets patient populations with conditions such as brain tumors, Alzheimer's disease, and Multiple Sclerosis.

4 investors

Breathe Well-being offers a mobile-based weight loss and lifestyle management program delivered through remote coaching, a mobile app with tracking and educational content, and peer support communities. The program targets people looking to prevent or manage chronic conditions like Type 2 Diabetes through behavioral coaching grounded in cognitive behavioral therapy and habit change techniques.

4 investors

BreatheSuite delivers pulmonary rehabilitation for COPD patients in a home-based format, combining physical therapy and respiratory therapy led by licensed clinicians. The service provides personalized care plans designed to improve breathing, strength, and overall well-being, accepting Medicare and major insurance coverage.

4 investors